NEW YORK, Feb. 26 /PRNewswire/ -- With over five million Americans suffering from heart failure, and more than half a million new cases diagnosed every year, it is the number one cause of hospitalization among individuals aged 65 and over, accounting for a yearly direct cost of care estimated at $100 billion, according to Kalorama Information's new report Congestive Heart Failure: Worldwide Device Markets.
Improvements in the care of other cardiac conditions are keeping more patients from dying due to sudden heart death. However, they become candidates for congestive heart failure several years down the road, leading to an increase in the importance of congestive heart failure as a cause of cardiovascular morbidity and mortality.
With this growing market demand, current and advanced technologies are being applied in the development of new therapeutic devices -- such as ICDs CRTs and ventricular assist devices -- and they are fueling substantial growth. Their impact on the major congestive heart failure markets in the United States, Europe and Japan is expected to appear in the next couple of years and the market for devices to treat congestive heart failure in these regions is expected to double in the next ten years.
"In many ways it is a hidden epidemic," notes the report's author, Ken Krul. "It doesn't get talked about as often as other diseases, but it consumes enormous resources. The United States Medicare system pays out more for the care of congestive heart failure than it does for all forms of cancer combined. And medical devices used to manage the disease are a large part of that spending."
Kalorama Information's new report Congestive Heart Failure: Worldwide Device Markets is the definitive measure of this large and growing market on a global scale. Based on primary and secondary research, the report covers the latest trends, forecasts and market conditions, reviews devices and new technologies, including ICDs, LVADs, artificial hearts, and pacemakers, as well as profiles of major players and market shares. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Congestive-Heart-Failure-1638430/.
About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. For more information, contact Tom Ehart at 240-747-3014 or email@example.com, or visit http://www.kaloramaInformation.com.
|SOURCE Kalorama Information|
Copyright©2008 PR Newswire.
All rights reserved